Elevated Lp(a) is the most frequent familial lipoprotein disorder leading to premature myocardial infarction in a country with low cholesterol levels

International Journal of Cardiology

Volumn 60, Issue 3, 1997, Pages 301-305

  Pay, Salih ^b   Özcan, Nurettin ^b   Tokgözoǧlu, S Lâle ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; TURKEY (REPUBLIC);

ADOLESCENT; APOLIPOPROTEINS B; CHOLESTEROL; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE IV; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NUCLEAR FAMILY; RISK FACTORS; TRIGLYCERIDES; TURKEY;

EID: 0030844305     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00107-1     Document Type: Article

References (15)

1. Slack J, Evans KA. The increased risk of death from ischemic heart disease in first degree relatives of 121 men and 96 women with ischemic heart disease. J Med Genet 1966;3:329.
2. Neufeld HN, Goldbourt U. Coronary heart disease: genetic aspects. Circulation 1983;67:943-54.
3. Goldstein JL, Hazzard WR, Schrott WR et al. Hyperlipidemia in coronary heart disease: I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 1973;52:1533-43.
4. Goldstein JL, Schrott WR, Hazzard WR et al. Hyperlipidemia in coronary heart disease: II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973;52:1544-68.
5. Nikkila EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet 1973;1:954-8.
6. Schaefer EJ, Genest Jr. JJ, Ordovas J, Salem DN, Wilson PWF. Familial lipoprotein disorders and premature coronary artery disease. Atherosclerosis 1994;108(Suppl):S41-54.
7. Genest Jr. JJ, Martin-Munlay SS, McNamara JR et al. Prevalence of familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992;85:2025-33.
8. Mahley RW, Palaoglu KE, Atak Z et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995;36:839-59.
9. Hoefler G, Harnoncourt F, Paschke E et al. Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis 1988;8:398-401.
10. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540.
11. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein (a) and the risk of myocardial infarction. JAMA 1993;270:2195-9.
12. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto Jr. AM. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;70:758-65.
13. Uterman G, Kraft HG, Menzel HJ, Hopferwieser T, Seitz C. Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum Genet 1988;78:41-6.
14. Marquez A, Mendosa S, Carrasco H, Hamer T, Glueck CJ. High lipoprotein (a) in children from kindreds with parenteral premature myocardial infarction. Pediatr Res 1993;34:670-4.
15. Örem A, Deger O, Önder E, Karahan SC, Efe H, Uzunosmanoǧlu D. Distribution of serum lipoprotein (a) concentrations in a healthy Turkish population. Ann Clin Biochem 1994;31:343-6.